Association of TMB using the Foundation Medicine Companion Diagnostic (F1CDx) with efficacy of first-line pembrolizumab (pembro) or pembro plus chemotherapy (pembro plus chemo) versus chemo in patients with gastric cancer (gc) from KEYNOTE-062

L. S. Wyrwicz, K-W. Lee, E. Van Cutsem, Y-J. Bang, C. S. Fuchs, I. Kudaba, M. Garrido, H. C. Chung, J. Lee, H. R. Castro, J. Chao, Z. A. Wainberg, Z. A. Cao, D. Aurora-Garg, J. Kobie, R. Cristescu, P. Bhagia, S. Shah, J. Tabernero, K. Shitara

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S907-S908
JournalAnnals of Oncology
Issue numberSuppl.4
Publication statusPublished - Sept 2020
Externally publishedYes
EventEuropean Society of Medical Oncology (ESMO) Virtual Congress - Virtual
Duration: 19 Sept 202021 Sept 2020

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this